Mounjaro®
Dual-agonist support that helps curb appetite, hunger, and cravings to drive substantial, sustained weight loss.
- ~22.5% average body weight loss
- Significant weight reduction
- Improves blood sugar levels
- Clinically proven weight loss

Many people prescribed Mounjaro (tirzepatide) for type 2 diabetes or weight management wonder: can you build muscle on Mounjaro? Whilst this dual GIP/GLP-1 receptor agonist effectively reduces appetite and promotes weight loss, concerns about muscle preservation are valid. Research shows that without proper intervention, 20–30% of weight lost during caloric restriction can come from lean tissue. However, with strategic resistance training, adequate protein intake, and careful nutritional planning, it is entirely possible to preserve and even build muscle whilst taking Mounjaro. This article explores evidence-based strategies to optimise body composition during treatment, ensuring you lose fat whilst maintaining or gaining muscle mass.
Summary: Yes, you can build muscle on Mounjaro with strategic resistance training, adequate protein intake (1.6–2.2 g/kg ideal body weight daily), and a moderate caloric deficit.
Mounjaro (tirzepatide) is a prescription medication licensed in the UK for the treatment of type 2 diabetes mellitus. In the UK, tirzepatide for weight management may be available under a different brand name according to the current Summary of Product Characteristics (SmPC). As a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist, Mounjaro works by mimicking naturally occurring incretin hormones that regulate blood glucose levels and appetite.
The medication's mechanism of action includes slowing gastric emptying, reducing appetite, and enhancing insulin secretion when blood glucose levels are elevated. These effects typically lead to reduced caloric intake and subsequent weight loss. Clinical trials (SURMOUNT-1, 2, 3, and 4) have demonstrated substantial weight reduction in patients taking tirzepatide, with average losses ranging from 15% to 22% of initial body weight depending on the dose, trial duration, and whether participants had diabetes. These trials included comprehensive lifestyle support alongside medication.
Body composition changes during weight loss are complex and extend beyond simple fat reduction. When individuals lose weight rapidly or without appropriate intervention, they typically lose both fat mass and lean body mass (which includes muscle tissue). Research suggests that approximately 20–30% of weight lost during caloric restriction can come from lean tissue if protective measures are not implemented. This phenomenon is particularly relevant for patients taking medications like Mounjaro, where appetite suppression may lead to significant caloric deficits.
Understanding these effects is crucial for patients who wish to maintain or build muscle mass whilst benefiting from Mounjaro's metabolic advantages. With proper nutritional strategies and resistance training, it is possible to preserve and even build muscle during treatment, though this requires deliberate effort and planning.

Weight loss medications, including GLP-1 and dual GIP/GLP-1 receptor agonists like Mounjaro, primarily facilitate weight reduction through appetite suppression and improved glycaemic control rather than directly affecting muscle tissue. However, the resulting caloric deficit and reduced food intake can indirectly impact muscle mass through several mechanisms.
Reduced protein intake is a primary concern when appetite is significantly suppressed. Patients taking Mounjaro often report feeling fuller for longer periods and consuming smaller portions. If dietary choices are not carefully managed, this can lead to inadequate protein consumption—the essential building block for muscle protein synthesis. Without sufficient dietary protein, the body may break down existing muscle tissue to meet its amino acid requirements. For muscle building, protein needs should be calculated using ideal body weight or fat-free mass in people with obesity, typically 1.6–2.2 grams per kilogram. People with chronic kidney disease should consult their healthcare provider before increasing protein intake.
The energy deficit created by reduced caloric intake also influences muscle preservation. Whilst a caloric deficit is necessary for fat loss, excessive deficits can trigger catabolic processes where the body breaks down muscle tissue for energy. This is particularly pronounced when weight loss occurs rapidly or when physical activity levels decrease due to reduced energy availability.
Hormonal changes accompanying significant weight loss may also affect muscle mass. Reductions in anabolic hormones such as insulin-like growth factor 1 (IGF-1) and testosterone can occur during prolonged caloric restriction, potentially impairing muscle protein synthesis. Additionally, increased cortisol levels associated with stress or inadequate recovery can promote muscle breakdown.
Lean mass reductions seen with tirzepatide mirror those expected from weight loss; myopathy is not a recognised adverse reaction in the SmPC. The key distinction is that muscle loss is not an inherent side effect of the medication but rather a consequence of how weight loss is managed. With appropriate interventions—adequate protein intake, resistance training, and monitored weight loss rates—muscle mass can be preserved or even increased whilst taking Mounjaro.
Important safety note for people with diabetes: If you take insulin or sulfonylureas, you may be at increased risk of hypoglycaemia (low blood glucose) during exercise and caloric restriction. Discuss medication adjustments with your diabetes care team and monitor your blood glucose levels carefully, especially around exercise sessions.
Building muscle whilst taking Mounjaro requires a strategic approach that balances the medication's appetite-suppressing effects with the nutritional and training demands of muscle growth. The following evidence-based strategies can help optimise body composition during treatment.
Prioritise progressive resistance training as the cornerstone of muscle preservation and growth. Engaging in structured strength training at least 2–3 times per week stimulates muscle protein synthesis and signals the body to maintain lean tissue even during weight loss. Exercises should target all major muscle groups, with progressive overload—gradually increasing weight, repetitions, or training volume—being essential for continued adaptation. Compound movements such as squats, deadlifts, bench presses, and rows are particularly effective for building overall muscle mass.
Implement a moderate caloric deficit rather than aggressive restriction. Whilst Mounjaro facilitates appetite reduction, consuming too few calories can compromise muscle-building efforts. A deficit of 300–500 calories below maintenance typically allows for steady fat loss (approximately 0.25–0.5 kg per week) whilst providing sufficient energy for muscle protein synthesis and recovery. Working with a healthcare professional or registered dietitian can help determine appropriate caloric targets based on individual factors.
Time your protein intake strategically throughout the day. Distributing protein across multiple meals (typically 3–5 servings) optimises muscle protein synthesis more effectively than consuming large amounts in one or two sittings. Aim for approximately 25–40 grams of high-quality protein per meal, with particular attention to post-exercise nutrition when muscles are most receptive to amino acids. During the initial weeks of treatment when gastrointestinal side effects may be more pronounced, smaller, more frequent protein-dense meals may be better tolerated.
Monitor your rate of weight loss carefully. Losing weight too rapidly increases the likelihood of muscle loss. If you're losing more than 1% of your body weight per week consistently, consider adjusting your caloric intake upward or consulting your healthcare provider. Slower, steady weight loss better preserves lean body mass and is more sustainable long-term, aligning with NICE guidance on obesity management.
Nutrition becomes particularly critical when attempting to build muscle whilst taking Mounjaro, as the medication's appetite-suppressing effects can make meeting nutritional requirements challenging. A strategic approach to dietary intake can help overcome these obstacles.
Protein intake should be the primary nutritional focus. Current evidence suggests that individuals engaged in resistance training whilst in a caloric deficit require higher protein intakes than those maintaining weight—typically 1.6–2.2 grams per kilogram of ideal body weight or fat-free mass daily. For people with obesity, calculating protein needs based on total body weight may overestimate requirements. For a 90 kg individual with an ideal body weight of 70 kg, this translates to approximately 112–154 grams of protein daily. High-quality protein sources include lean meats, poultry, fish, eggs, dairy products, legumes, and plant-based alternatives such as tofu and tempeh. If appetite suppression makes consuming adequate protein through whole foods difficult, protein supplements (whey, casein, or plant-based powders) can help bridge the gap. People with chronic kidney disease or other conditions affecting protein metabolism should consult their healthcare provider before increasing protein intake.
Leucine-rich foods deserve special attention, as this branched-chain amino acid is particularly effective at stimulating muscle protein synthesis. Foods high in leucine include dairy products (especially Greek yoghurt and cottage cheese), eggs, chicken, beef, and soya products. Aiming for approximately 2–3 grams of leucine per meal can optimise the muscle-building response.
Carbohydrate intake should not be neglected, despite common misconceptions about low-carbohydrate diets and weight loss. Carbohydrates provide the primary fuel for resistance training and help preserve muscle glycogen stores. They also have a protein-sparing effect, meaning adequate carbohydrate availability reduces the body's need to break down muscle tissue for energy. Complex carbohydrates such as whole grains, oats, sweet potatoes, and legumes provide sustained energy and important micronutrients.
Micronutrient adequacy is essential for muscle function and recovery. Particular attention should be paid to vitamin D, calcium, magnesium, iron, and zinc—all of which play roles in muscle contraction, protein synthesis, and recovery. A varied diet rich in fruits, vegetables, whole grains, and lean proteins typically provides adequate micronutrients. A food-first approach is recommended; consider supplements only after assessment by a healthcare professional or registered dietitian if dietary intake is significantly restricted.
Hydration and electrolytes require special attention, particularly if you experience gastrointestinal side effects like nausea, vomiting, or diarrhoea. Aim for at least 2 litres of fluid daily, increasing intake during exercise or hot weather.
A well-structured exercise programme is fundamental to building muscle whilst taking Mounjaro. The following recommendations are based on current exercise science and UK Chief Medical Officers' Physical Activity Guidelines.
Resistance training should form the foundation of your exercise routine. Aim for at least 2–4 sessions per week, allowing 48 hours of recovery between training the same muscle groups. Each session should include:
Compound exercises targeting multiple muscle groups (squats, deadlifts, bench press, rows, overhead press)
6–12 repetitions per set for hypertrophy (muscle growth), performed to near-failure
3–4 sets per exercise with 2–3 minutes rest between sets
Progressive overload by gradually increasing weight, repetitions, or volume over time
Beginners should consider working with a qualified personal trainer or physiotherapist to learn proper form and develop an appropriate programme. Poor technique increases injury risk and reduces training effectiveness.
Cardiovascular exercise can be incorporated for overall health and additional caloric expenditure, but should be balanced carefully to avoid interfering with muscle-building goals. Excessive cardio can create an energy deficit that compromises recovery and muscle growth. Moderate-intensity activities such as brisk walking, cycling, or swimming for 150 minutes per week (as recommended by UK Chief Medical Officers) support cardiovascular health without significantly impeding muscle development. High-intensity interval training (HIIT) can be effective but should be limited to 1–2 sessions weekly to prevent overtraining, and may need to be introduced gradually, especially during dose escalation.
Recovery and rest are often underestimated components of muscle building. Muscles grow during recovery periods, not during training itself. Ensure adequate sleep (7–9 hours nightly), as sleep deprivation impairs muscle protein synthesis and recovery. Additionally, manage training volume appropriately—more is not always better. Overtraining can lead to elevated cortisol levels, increased injury risk, and paradoxically, muscle loss.
Listen to your body during the initial months of Mounjaro treatment. Some patients experience fatigue or gastrointestinal side effects that may temporarily affect exercise capacity. If you feel unusually fatigued, dizzy, or unwell during exercise, reduce intensity and consult your healthcare provider.
For people with diabetes: If you take insulin or sulfonylureas, check your blood glucose before, during (for longer sessions), and after exercise. Discuss medication adjustments with your diabetes care team to reduce hypoglycaemia risk. Those with diabetes complications (neuropathy, retinopathy, cardiovascular disease) should seek medical clearance and individualised exercise guidance.
Tracking your progress whilst taking Mounjaro helps ensure you're building muscle effectively and losing weight safely. Regular monitoring also helps identify when professional guidance may be needed.
Body composition assessment provides more valuable information than weight alone. Whilst bathroom scales show total weight changes, they don't distinguish between fat loss and muscle loss. Consider these monitoring methods:
Circumference measurements of arms, chest, waist, hips, and thighs taken monthly
Progress photographs from consistent angles and lighting every 2–4 weeks
Strength progression tracking weights lifted and repetitions completed
Body composition analysis through bioelectrical impedance scales (home use) or DEXA scans (most accurate, generally available through private healthcare services rather than the NHS, where DEXA is primarily used for bone density assessment)
These metrics collectively provide a clearer picture of body composition changes than weight alone.
Performance indicators in the gym are excellent markers of muscle preservation or growth. If your strength is maintaining or increasing whilst losing weight, you're likely preserving or building muscle mass. Conversely, significant strength decreases may indicate excessive muscle loss and warrant dietary or training adjustments.
When to contact your GP or healthcare provider:
Rapid weight loss exceeding 1.5 kg per week consistently
Significant strength decreases or unusual fatigue during normal activities
Persistent gastrointestinal symptoms preventing adequate nutrition
Signs of dehydration including dark urine, dizziness, or confusion
Muscle pain or weakness unrelated to exercise
Difficulty consuming adequate protein despite dietary modifications
Severe, persistent abdominal pain (with or without vomiting) which may indicate pancreatitis
Right upper quadrant pain, fever, or jaundice which may indicate gallbladder disease
For people with diabetes: recurrent hypoglycaemia during weight loss or exercise
Your prescribing clinician should monitor your progress regularly, typically with appointments every 3–6 months. These reviews should include weight, blood pressure, HbA1c (if diabetic), and discussion of any side effects or concerns. NICE guidance recommends regular monitoring of patients on weight management medications to assess efficacy and safety, with specific continuation criteria based on achieving and maintaining clinically significant weight loss.
If you're struggling to balance muscle building with Mounjaro treatment, consider requesting a referral to a registered dietitian through your GP. Dietitians can provide personalised nutritional strategies that accommodate the medication's effects whilst supporting your body composition goals. Similarly, if you have pre-existing musculoskeletal conditions or are new to resistance training, physiotherapy services can provide safe, effective exercise programming tailored to your needs and capabilities.
If you experience any suspected side effects from Mounjaro, report them through the MHRA Yellow Card scheme (yellowcard.mhra.gov.uk or the Yellow Card app).
Individuals engaged in resistance training whilst taking Mounjaro typically require 1.6–2.2 grams of protein per kilogram of ideal body weight or fat-free mass daily. For people with obesity, calculate protein needs based on ideal body weight rather than total body weight to avoid overestimation.
Mounjaro does not directly cause muscle loss; myopathy is not a recognised adverse reaction. However, the appetite suppression and resulting caloric deficit can lead to muscle loss if protein intake is inadequate or resistance training is not performed. With proper nutrition and exercise, muscle can be preserved or built during treatment.
Aim for at least 2–4 resistance training sessions per week, targeting all major muscle groups with compound exercises. Allow 48 hours of recovery between training the same muscle groups, and use progressive overload by gradually increasing weight, repetitions, or volume over time.
The health-related content published on this site is based on credible scientific sources and is periodically reviewed to ensure accuracy and relevance. Although we aim to reflect the most current medical knowledge, the material is meant for general education and awareness only.
The information on this site is not a substitute for professional medical advice. For any health concerns, please speak with a qualified medical professional. By using this information, you acknowledge responsibility for any decisions made and understand we are not liable for any consequences that may result.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.
Block quote
Ordered list
Unordered list
Bold text
Emphasis
Superscript
Subscript